PipelinePharma Logo

Generics 19

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Dexlansoprazole manufacturers

19 products found

Filters

dexlansoprazole

Capsules, modified release (MR) 30 mg, 60 mg

Dossier type
US CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
FDA, EU GMP
Comments
Dossier availability date: Q2 2025 Ref. Dexilant
Manufacturer #31058
This company, based in Europe, is a pharmaceutical manufacturer with a history spanning over seven decades. They focus on the development, production, and marketing of generic and value-added medicines, catering to patients globally. Their expertise lies in complex generics and their portfolio includes prescription drugs and over-the-counter medications. They hold significant experience in the industry, with strong manufacturing capabilities in Europe and North America, backed by GMP certifications. The company has a robust track record of growth, demonstrated by its international presence and expansion into key regions such as Europe and North America. Key therapy areas include cardiovascular, oncology, and gastrointestinal disorders. Their production lines include solid dosage forms, injectables, and liquids.

Manufacturer usually replies in 8 days

dexlansoprazole

Capsules 30 mg, 60 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only, Technology transfer
Manufacturer #22627
This pharmaceutical company was founded in 2007 and has two manufacturing facilities strategically located in India. They boast over 1,800 products spanning a range of therapeutic areas, including those focused on dermatology, pain management, and possibly central nervous system disorders based on the listed divisions. The company produces both prescription medications and over-the-counter drugs, utilizing diverse dosage forms such as tablets and capsules. They maintain a strong national network for distribution and a global presence. GMP certifications are likely held due to their focus on quality manufacturing practices.

Manufacturer usually replies in 4 days

dexlansoprazole

Capsules 30 mg, 60 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #13225
It is an Indian manufacturer that is active in 40+ countries. They are in this line of business for 85+ years. The company has a more than $150 million turnover. The company manufactures and distributes more than 100 APIs and 200 formulations which is responsible for 25000+ SKUs. Quality control and quality assurance are one of the focus areas for the company.

Manufacturer usually replies in 4 days

Want to see all 19 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation